Keywords: warner-lambert, lipitor, purchase, agouron, boosts, net, income
Warner-Lambert's Lipitor and purchase of Agouron boosts net income by 36%
Article | 23 July 1999
Warner-Lambert says that second-quarter net income rose 36% to $447million, while revenues climbed 17% to $3.15 billion, boosted by sales of the lipid-lowerer ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
